
Eli Lilly's Oral Weight-Loss Pill Works Better in Older Adults
Eli Lilly's FDA-approved GLP-1 pill delivered 13% average weight loss in adults 65 and older—above the overall trial average of 12.4%. This matters because older adults often struggle with injectable versions due to swallowing difficulties and complex medication schedules. An oral form could significantly boost uptake in nursing homes and home care, where obesity compounds other health problems.
Published